Elicit Plant raises cash for biostimulants

The French start-up Elicit Plant, one of C&EN’s 10 Start-Ups to Watch in 2023 , has raised $47 million to commercialize products that help protect crop yields during drought. The products are composed of phytosterols, molecules that regulate a plant’s response to stressors. Earlier this year, the firm announced partnerships with BASF and Bayer to develop biostimulants for crops in France. Elicit plans to launch products in the US next year.

Authors

Publication Details

Journal
C&EN Global Enterprise
Published
2024-11-25
DOI
https://doi.org/10.1021/cen-10237-buscon11
Primary Topic
Land Use and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Elicit Plant raises cash for biostimulants

Matt Blois
C&EN Global Enterprise
Land Use and Management
article

Elicit Plant raises cash for biostimulants

Matt Blois
article en

Abstract

The French start-up Elicit Plant, one of C&EN’s 10 Start-Ups to Watch in 2023 , has raised $47 million to commercialize products that help protect crop yields during drought. The products are composed of phytosterols, molecules that regulate a plant’s response to stressors. Earlier this year, the firm announced partnerships with BASF and Bayer to develop biostimulants for crops in France. Elicit plans to launch products in the US next year.

C&EN Global EnterpriseVol. 102(37)
Zero hunger
Openalex Percentile: Top 66%
Land Use and Management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Elicit Plant raises cash for biostimulants — Matt Blois · C&EN Global Enterprise (2024) | TGRS Research Map | TGRS